Difference in differences with infectious disease outcomes

Alyssa Bilinski
Additional contact information
Alyssa Bilinski: Brown University

Biostatistics and Epidemiology Virtual Symposium 2025 from Stata Users Group

Abstract: Researchers frequently employ difference in differences (DiD) to study the impact of public health interventions on infectious disease outcomes. DiD assumes that treatment and nonexperimental comparison groups would have moved in parallel in expectation, absent the intervention (“parallel-trends assumption”). However, the plausibility of the parallel-trends assumption in the context of infectious disease transmission is not well understood. Our work bridges this gap by formalizing epidemiological assumptions required for common DiD specifications, positing an underlying susceptible-infectious-recovered (SIR) data-generating process. We demonstrate that popular specifications can encode strict epidemiological assumptions. For example, DiD modeling incident case numbers or rates as outcomes will produce biased treatment-effect estimates unless untreated potential outcomes for treatment and comparison groups come from a data-generating process with the same initial infection and equal transmission rates at each time step. Applying a log transformation or modeling log growth allows for different initial infection rates under an “infinite susceptible population” assumption but invokes conditions on transmission parameters. We then propose alternative DiD specifications based on epidemiological parameters, the effective reproduction number and the effective contact rate, that are both more robust to differences between treatment and comparison groups and can be extended to complex transmission dynamics. With minimal power difference incidence and log-incidence models, we recommend a default of the more robust log specification. Our alternative specifications have lower power than incidence or log-incidence models but have higher power than log-growth models. We illustrate implications of our work by reanalyzing published studies of COVID-19 mask policies.

Date: 2025-03-05
References: Add references at CitEc
Citations:

Downloads: (external link)
http://repec.org/biep2025/Bio25_Bilinski.pdf presentation materials (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:boc:biep25:06

Access Statistics for this paper

More papers in Biostatistics and Epidemiology Virtual Symposium 2025 from Stata Users Group Contact information at EDIRC.
Bibliographic data for series maintained by Christopher F Baum ().